Neuronetics, Inc. is a commercial-stage medical technology company. Co. is focused on designing, developing and marketing products for patients who suffer from neurohealth disorders. Its commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation (TMS) to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The NeuroStar Advanced Therapy System is used to treat adult patients with major depressive disorder (MDD). We show 26 historical shares outstanding datapoints in our STIM shares outstanding history coverage, used to compute STIM market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing STIM market cap history over the course of time is important for investors
interested in comparing STIM's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of STIM versus a peer is one thing; comparing
STIM market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like STIM can fluctuate over the course of history.
With this page we aim to empower investors researching STIM by allowing them to research the STIM market cap history. |
Free STIM Email Alerts:
Video: The Importance of Market Cap
